Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice

by Peter E. Penson, Maciej Banach
Published 2021-08-01

LDL-C: lower is better for longer—even at low risk

by Peter E. Penson, Matteo Pirro, Maciej Banach
Published 2020-10-01

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective

by Zlatko Fras, Borut Jug, Peter E. Penson, Manfredi Rizzo
Published 2021-09-01

The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis

by Sajad Dehnavi, Mahvash Sadeghi, Peter E. Penson, Maciej Banach, Tannaz Jamialahmadi, Amirhossein Sahebkar
Published 2019-11-01

Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

by Armita Mahdavi Gorabi, Nasim Kiaie, Saeideh Hajighasemi, Maciej Banach, Peter E. Penson, Tannaz Jamialahmadi, Amirhossein Sahebkar
Published 2019-11-01

Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in Bahrain

by Haitham Jahrami, Mana Al-Mutarid, Peter E. Penson, Mo’ez Al-Islam Faris, Zahra Saif, Layla Hammad
Published 2020-04-01

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label condi...

by Peter E. Penson, G. B. John Mancini, Peter P. Toth, Seth S. Martin, Gerald F. Watts, Amirhossein Sahebkar, Dimitri P. Mikhailidis, Maciej Banach, on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP)
Published 2018-12-01